Former opponents 1 and 2 had withdrawn their oppositions during the opposition proceedings. The further respondent and opponent 3, LG Chem. In its reply received on 30 November 2007 opponent 4, Avery Denison Corporation, hereinafter: "the respondent", requested that the appeal be dismissed and also, as auxiliary request, oral proceedings. In the statement setting out the grounds of appeal received on the appellant requested that the decision of the opposition division be set aside and that the patent be maintained on the basis of the set of claims of the main request filed therewith or, as a further auxiliary request, that oral proceedings be arranged. On 6 March 2007 the patent proprietor filed an appeal against this decision and paid the appeal fee on the same day. P19_P11a: Picture having a higher magnification of the three pages product sheet P19_11 of "Stimsonite Series 4500 Metallized Retroreflective Sheeting". P19_P10: Graphs showing the calculated geometrical efficiency of a "Stimsonite Series 4500 Metallized Retroreflective Sheeting" (2 pages) Furthermore, the following documents were relied on by the parties in the proceedings: the claims of the patent as granted, did not comply with the requirements of Article 123(2) EPC and the claims of the auxiliary request did not involve an inventive step (Article 56 EPC), starting from the embodiment in document P20 (WO-A-96/42023), Fig. In the division's opinion, the claims of the main request, i.e. 96942885.3) was revoked by the decision of the opposition division dated 4 January 2007. EPAC - European patent administration certification.Pan-European Seal Young Professionals Programme.Intellectual property course design manual.Universities, research centres and technology transfer centres (TTOs).Learning material for formalities officers and paralegals.Learning material for examiners of national officers.The jurisdiction of European courts in patent disputes.European qualifying examination - Guide for preparation.For stakeholders of the innovation ecosystem.Support for high-growth technology businesses. What if your idea is not novel but does have commercial potential?.Podcast series on IP as key commercial asset.Nucleic acids and antibodies to fight coronavirus.Candidate antiviral and symptomatic therapeutics.Overview of candidate therapies for COVID-19.Energy storage and other enabling technologies.National measures relating to the Unitary Patent.Implementing regulations to the EPC 2000.Diplomatic Conference for the revision of the EPC.Technical information for batch payments.What if our online filing services are down?.Public access to opposition proceedings.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |